CVRdatabase
Menu

Perfusion Tech ApS

Private limited companyCVR 38238213København ØActive

Perfusion Tech ApS is a private limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2016. Equity was negative at the end of 2025 (−DKK 9.6m). The company made a loss in both 2024 and 2025, most recently DKK 12.7m.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profit−DKK 6.1m+31.9% vs. 2024
Net profit−DKK 12.7m+12.1% vs. 2024
Equity−DKK 9.6m−556% vs. 2024
Employees6latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • The loss got smaller: from DKK 14.5m to DKK 12.7m (2024 → 2025).
  • Equity turned negative: −DKK 9.6m (2024 → 2025).

Employees

  • 7 fewer employees than a year earlier: 6 (07/2026) against 13 (07/2025).

Management and owners, last 24 months

  • New in management: Declan Cassells (director, 29/09/2025).
  • Stepped down: Jeppe Øvli Øvlesen (board member, 04/06/2025), Thomas Engelbrecht Nordkild Jonassen (board member, 04/06/2025) and Sten Scheibye (board member, 22/04/2025) (+3).
  • New owners registered: Renew Pharmaceuticals Limited (04/06/2025), M.T. Lund Holdings ApS (12/12/2024) and MHAaM Holdings ApS (12/12/2024).
  • No longer registered as owner: M.T. Lund Holdings ApS (11/12/2024), MHAaM Holdings ApS (11/12/2024) and TJ Biotech Holding ApS (04/06/2025) (+4).

Registrations, last 24 months

  • 21/01/2026: Share capital changed from 106,549 DKK to 118,457 DKK
  • 04/06/2025: Share capital changed from 102,140 DKK to 106,549 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
  • 12/12/2024: Share capital changed from 96,742 DKK to 102,140 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 16m−DKK 14m−DKK 12m−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0DKK 2m202020212022202320242025
EquityNet profit
Financial figures for Perfusion Tech ApS
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit−1,092−1,067−4,201−5,414−9,022−6,143+31.9%
Operating profit (EBIT)−1,618−2,413−7,563−10,706−16,402−14,435+12%
Profit before tax−1,712−2,693−7,833−11,013−16,691−14,828+11.2%
Net profit−1,486−2,118−6,556−9,545−14,470−12,725+12.1%
Total assets6861,2644,8888,8325,5854,587−17.9%
Equity−1,815−3,9321,1702,8732,114−9,641−556%
Liabilities2,5015,1973,7185,9593,47114,227+309.9%
Cash and cash equivalents3624033,4355,9692,3221,523−34.4%
Average number of employees347811110%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 10m−DKK 8m−DKK 6m−DKK 4m−DKK 2mDKK 0202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Negative equity

    Equity was −DKK 9.6m at the end of 2025.

    How is this calculated?

    Equity in the latest annual report is below zero.

  • Loss for 6 years in a row

    Net result has been negative in 2020–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Perfusion Tech ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202509/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202424/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202325/03/2024The companyPDFXBRL
202201/01/2022 – 31/12/202207/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202127/05/2022The companyPDFXBRL
202001/01/2020 – 31/12/202026/05/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
024681012141608/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 6.1mNo. 378 of 421
Better than 10% of the companies in the industry
Equity−DKK 9.6mNo. 401 of 431
Better than 7% of the companies in the industry
Number of employees6No. 135 of 431
Better than 69% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 69,571of 69,742
Better than 0%
No. 69,577of 69,964
Better than 1%
Same industry and fewer than 20 employees329 companies in the comparison
No. 297of 323
Better than 8%
No. 310of 329
Better than 6%
Companies that are between 5 and 14 years old33,679 companies in the comparison
No. 33,445of 33,579
Better than 0%
No. 33,338of 33,678
Better than 1%
All companies of type ApS66,508 companies in the comparison
No. 66,225of 66,379
Better than 0%
No. 66,109of 66,505
Better than 1%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Perfusion Tech ApS−DKK 6.1m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Perfusion Tech ApS−DKK 12.7m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Perfusion Tech ApS−DKK 9.6m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Perfusion Tech ApS6
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Renew Pharmaceuticals Limited100%
Perfusion Tech ApS

Management

2 active registrations

Executive management

Executive management at Perfusion Tech ApS
NameRoleAppointed
Declan CassellsDirector29/09/2025

Board of directors

Board of directors at Perfusion Tech ApS
NameRoleAppointed
Declan CassellsBoard member22/09/2023
Founders
M.T. Lund Holdings ApS, MHAaM Holdings ApS
Former management (14)
Former management at Perfusion Tech ApS
NameRoleAppointedResigned
Mads Aagaard Linde MadsenCEO28/11/201601/10/2023
Jeppe Øvli ØvlesenBoard member25/10/201704/06/2025
Steffen Boutrup MøllerBoard member25/10/201708/12/2020
Thomas Engelbrecht Nordkild JonassenBoard member25/10/201704/06/2025
Morten Asp Vonsild LundChair of the board25/10/201721/09/2023
Mads Aagaard Linde MadsenBoard member25/10/201724/10/2022
Lars Henning StigelBoard member08/12/202022/09/2023
Henrik ChristensenBoard member21/03/202221/09/2023
Pernille Charlotte SingerDirector01/10/202230/09/2023
Sten ScheibyeBoard member24/10/202222/04/2025
Henrik ChristensenChair of the board22/09/202304/06/2025
Morten Asp Vonsild LundBoard member22/09/202313/03/2024
Pernille Charlotte SingerCEO01/10/202329/09/2025
Mads Aagaard Linde MadsenBoard member13/03/202404/06/2025

Signing rule: Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse i forening.

Address and production units

1 active production units

Viborggade 70D
2100 København Ø

København Municipality · Postcode 2100

Other companies at the address (2)

  • Cameo Film A/SMotion picture, video and television programme post-production
  • Hitch A/SMotion picture, video and television programme production
Production units
Production unitAddressEmployeesP number
Perfusion Tech ApSViborggade 70D, 1, 2100 København Ø61021987685

Purpose

Selskabet har til formål at udvikle, markedsføre og kommercialisere medicinsk udstyr, herunder ved gennemførelse af forsknings- og udviklingsaktiviteter, og andre hermed relaterede aktiviteter.

The purpose is quoted from the register in Danish.

Changes year by year

101 registered events
20262 changesaccounts 1 · capital 1
  • Annual report for 2025 published
  • Share capital changed from 106,549 DKK to 118,457 DKK
202516 changesmanagement 7 · accounts 1 · capital 1 · ownership 6 · industry 1
  • Declan Cassells appointed director
  • Pernille Charlotte Singer stepped down as ceo
  • Annual report for 2024 published
  • Share capital changed from 102,140 DKK to 106,549 DKK
  • Mads Aagaard Linde Madsen stepped down as board member
  • Henrik Christensen stepped down as chair of the board
  • Thomas Engelbrecht Nordkild Jonassen stepped down as board member
  • Jeppe Øvli Øvlesen stepped down as board member
  • Renew Pharmaceuticals Limited registered as owner (100%)
  • M.T. Lund Holdings ApS is no longer registered as owner
  • MHAaM Holdings ApS is no longer registered as owner
  • Quantass ApS is no longer registered as owner
  • TJ Biotech Holding ApS is no longer registered as owner
  • Renew Pharmaceuticals Limited is no longer registered as owner
  • Sten Scheibye stepped down as board member
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
202413 changescapital 2 · ownership 8 · accounts 1 · management 2
  • Share capital changed from 96,742 DKK to 102,140 DKK
  • M.T. Lund Holdings ApS registered as owner (10%)
  • MHAaM Holdings ApS registered as owner (10%)
  • M.T. Lund Holdings ApS is no longer registered as owner
  • MHAaM Holdings ApS is no longer registered as owner
  • Share capital changed from 84,866 DKK to 96,742 DKK
  • Quantass ApS registered as owner (5%)
  • Renew Pharmaceuticals Limited registered as owner (25%)
  • Renew Pharmaceuticals Limited is no longer registered as owner
  • Quantass ApS is no longer registered as owner
  • Annual report for 2023 published
  • Mads Aagaard Linde Madsen appointed board member
  • Morten Asp Vonsild Lund stepped down as board member
202324 changesaddress 1 · management 9 · capital 3 · ownership 10 · accounts 1
  • Moved to Viborggade 70D, 1, 2100 København Ø
  • Pernille Charlotte Singer appointed ceo
  • Mads Aagaard Linde Madsen stepped down as ceo
  • Pernille Charlotte Singer stepped down as director
  • Share capital changed from 79,741 DKK to 84,866 DKK
  • Declan Cassells appointed board member
  • Morten Asp Vonsild Lund appointed board member
  • Henrik Christensen appointed chair of the board
  • Lars Henning Stigel stepped down as board member
  • Renew Pharmaceuticals Limited registered as owner (15%)
  • M.T. Lund Holdings ApS registered as owner (15%)
  • TJ Biotech Holding ApS registered as owner (5%)
  • MHAaM Holdings ApS registered as owner (15%)
  • Uddannelses- og Forskningsstyrelsen is no longer registered as owner
  • Henrik Christensen stepped down as board member
  • Morten Asp Vonsild Lund stepped down as chair of the board
  • M.T. Lund Holdings ApS is no longer registered as owner
  • MHAaM Holdings ApS is no longer registered as owner
  • TJ Biotech Holding ApS is no longer registered as owner
  • Uddannelses- og Forskningsstyrelsen registered as owner (5%)
  • Uddannelses- og Forskningsstyrelsen is no longer registered as owner
  • Share capital changed from 79,731 DKK to 79,741 DKK
  • Annual report for 2022 published
  • Share capital changed from 73,096 DKK to 79,731 DKK
202213 changesmanagement 4 · capital 2 · accounts 1 · ownership 6
  • Sten Scheibye appointed board member
  • Mads Aagaard Linde Madsen stepped down as board member
  • Pernille Charlotte Singer appointed director
  • Share capital changed from 68,760 DKK to 73,096 DKK
  • Annual report for 2021 published
  • Share capital changed from 54,377 DKK to 68,760 DKK
  • Henrik Christensen appointed board member
  • Quantass ApS registered as owner (10%)
  • M.T. Lund Holdings ApS registered as owner (20%)
  • MHAaM Holdings ApS registered as owner (20%)
  • TJ Biotech Holding ApS registered as owner (10%)
  • MHAaM Holdings ApS is no longer registered as owner
  • M.T. Lund Holdings ApS is no longer registered as owner
20213 changesaddress 2 · accounts 1
  • Moved to Læssøesgade 20, kl. tv, 2200 København N
  • Annual report for 2020 published
  • Moved to Slangerupgade 6, 3. th, 2200 København N
20205 changesownership 2 · management 2 · address 1
  • QUANTASS ApS is no longer registered as owner
  • TJ BIOTECH HOLDING ApS is no longer registered as owner
  • Lars Henning Stigel appointed board member
  • Steffen Boutrup Møller stepped down as board member
  • Moved to Ryesgade 107, 3. 2, 2100 København Ø
20196 changescapital 2 · ownership 4
  • Share capital changed from 53,423 DKK to 54,377 DKK
  • QUANTASS ApS registered as owner (10%)
  • TJ BIOTECH HOLDING ApS registered as owner (10%)
  • QUANTASS ApS is no longer registered as owner
  • TJ BIOTECH HOLDING ApS is no longer registered as owner
  • Share capital changed from 50,000 DKK to 53,423 DKK
20181 changeaddress 1
  • Moved to Universitetsparken 7, Himmelev, 4000 Roskilde
201710 changesname 1 · capital 1 · management 5 · ownership 3
  • Name changed from Perfusion Tech IVS to Perfusion Tech ApS
  • Share capital changed from 1,000 DKK to 50,000 DKK
  • Morten Asp Vonsild Lund appointed chair of the board
  • Thomas Engelbrecht Nordkild Jonassen appointed board member
  • Steffen Boutrup Møller appointed board member
  • Jeppe Øvli Øvlesen appointed board member
  • Mads Aagaard Linde Madsen appointed board member
  • Uddannelses- og Forskningsstyrelsen registered as owner (10%)
  • Uddannelses- og Forskningsstyrelsen is no longer registered as owner
  • ASBA CONSULTING ApS is no longer registered as owner
20168 changesfounded 1 · management 1 · ownership 6
  • Registered as Perfusion Tech IVS
  • Mads Aagaard Linde Madsen appointed ceo
  • QUANTASS ApS registered as owner (15%)
  • Uddannelses- og Forskningsstyrelsen registered as owner (5%)
  • TJ BIOTECH HOLDING ApS registered as owner (15%)
  • ASBA CONSULTING ApS registered as owner (15%)
  • MHAaM Holdings ApS registered as owner (25%)
  • M.T. Lund Holdings ApS registered as owner (25%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction